New Drug Discovery and Development (PDF)
(Sprache: Englisch)
A case history approach to drug synthesis and discovery
Discover the origins of some of today's most popular drug
therapies. Explore case histories and gain insight into major
classes of antibiotics, antiviral drugs, analgesics, steroids,
compounds...
Discover the origins of some of today's most popular drug
therapies. Explore case histories and gain insight into major
classes of antibiotics, antiviral drugs, analgesics, steroids,
compounds...
sofort als Download lieferbar
eBook (pdf)
129.99 €
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenloser tolino webreader
Produktdetails
Produktinformationen zu „New Drug Discovery and Development (PDF)“
A case history approach to drug synthesis and discovery
Discover the origins of some of today's most popular drug
therapies. Explore case histories and gain insight into major
classes of antibiotics, antiviral drugs, analgesics, steroids,
compounds designed to lower cholesterol, and more. Review the steps
required for FDA approval. This is a great reference for
students in medicinal chemistry, researchers in pharmaceuticals,
and medical practitioners.
Discover the origins of some of today's most popular drug
therapies. Explore case histories and gain insight into major
classes of antibiotics, antiviral drugs, analgesics, steroids,
compounds designed to lower cholesterol, and more. Review the steps
required for FDA approval. This is a great reference for
students in medicinal chemistry, researchers in pharmaceuticals,
and medical practitioners.
Inhaltsverzeichnis zu „New Drug Discovery and Development (PDF)“
Preface. 1. Antibiotics. 2. Antiviral Drugs. 3. Antihypertensive Agents. 4. Lipid Lowering Drugs. 5. Centrally Acting Analgesics. 6. Nonopiate Analgesic Agents. 7. Steroids. 8. Histamine. 9. From Lab Bench to Pharmacy Shelf. Appendix. Index.
Autoren-Porträt von Daniel Lednicer
DANIEL LEDNICER, PhD, is the acclaimed author of several books on drug synthesis and discovery. His career in both the private and public sectors has been devoted to the search for new therapeutic agents. Dr. Lednicer spent two decades at the bench as a chemist at the Upjohn Company. Following that, he served as director of chemical research at Mead Johnson, director of pharmaceutical sciences at Adria Laboratories, and pharmaceutical manager at Analytical Biochemistry Laboratories. Most recently, he was a project officer at the National Cancer Institute.
Bibliographische Angaben
- Autor: Daniel Lednicer
- 2007, 1. Auflage, 216 Seiten, Englisch
- Verlag: John Wiley & Sons
- ISBN-10: 0470068264
- ISBN-13: 9780470068267
- Erscheinungsdatum: 04.01.2007
Abhängig von Bildschirmgröße und eingestellter Schriftgröße kann die Seitenzahl auf Ihrem Lesegerät variieren.
eBook Informationen
- Dateiformat: PDF
- Größe: 2.78 MB
- Mit Kopierschutz
Sprache:
Englisch
Kopierschutz
Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.
Kommentar zu "New Drug Discovery and Development"
Schreiben Sie einen Kommentar zu "New Drug Discovery and Development".
Kommentar verfassen